TENFU (06868) Confirms No Injection of IPO Proceeds to Chinese Subsidiaries by Taiwan Shareholders in H2 2025, Full Compliance with Cross-Strait Investment Regulations

Stock News
01/22

According to an announcement from TENFU (06868), investments by Taiwanese investors (including individuals and enterprises) in the People's Republic of China, whether direct or indirect and conducted through companies they control, are subject to approval from Taiwan's Investment Commission. Under the cross-strait investment regulations, such investments require prior approval from the Investment Commission; however, an exception allows for post-investment filing within six months if the total cumulative investment by all Taiwanese investors in a single Chinese entity does not exceed US$1 million. As disclosed in the prospectus, the company has several Taiwanese founders, namely Mr. Li Ruibe and Mr. Zeng Mingshun, along with 81 original Taiwanese investors, who are required to comply with these regulations when injecting the proceeds from the company's listing on the Main Board of The Stock Exchange of Hong Kong Limited into its Chinese subsidiaries. During the six-month period from July 1, 2025, to December 31, 2025, the company did not inject any listing proceeds into its Chinese subsidiaries. The company is pleased to announce its full compliance with the aforementioned cross-strait investment regulations throughout this period.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10